Dr Alan G Ramsay

Group leader @KingsCollegeLon // Interest in #CLL & #Lymphoma immunology, #TumorMicroenvironment, #Immunosuppression and pre-clinical translation.

[Dr Alan G Ramsay @RamsayLab]

@Stansted_Exp Hi, will trains run from Liverpool Street station to Stansted tomorrow morning (2 Jan) ?

[Dr Alan G Ramsay @RamsayLab]

Congratulations ! Fascinating vascular pericyte biology and translation

[Giulia De Rossi 🔬👀🤯 @GDR_tweets]

📢Our new paper is out in @ScienceTM 📢

Diabetic retinopathy (DR) is a leading cause of blindness. Patients show vascular changes in their retinas long before vision starts to deteriorate.
What triggers these early defects? Could targeting them prevent vision loss? 🧵

[Giulia De Rossi 🔬👀🤯 @GDR_tweets]

📢Our new paper is out in @ScienceTM 📢

Diabetic retinopathy (DR) is a leading cause of blindness. Patients show vascular changes in their retinas long before vision starts to deteriorate.
What triggers these early defects? Could targeting them prevent vision loss? 🧵

[Dr Alan G Ramsay @RamsayLab]

Thanks @LisaWhittaker02 - what an incredibly helpful exercise ! Look forward to more

[Lisa Whittaker @LisaWhittaker02]

Great to hear Dr Alan Ramsay @KingsCollegeLon present his research to the South East London Cancer Research Panel @kingshealth Alan’s work focusses on lymphoma but is relevant to all cancers including lung cancer #PPI #CancerResearch #lymphoma #bloodcancer @BloodCancer_Res

[Dr Alan G Ramsay @RamsayLab]

We are honoured, thank you to all our collaborators, patients and supporters

[Blood Journals Portfolio @BloodPortfolio]

🚨📣The Blood Art Contest winner has been selected! 🎉Congratulations to Alan G. Ramsay and co-authors! @ramsaylab @kingscollegelon
https://t.co/fzanknMEyL #bloodjournals

[Blood Journals Portfolio @BloodPortfolio]

12 covers have been selected for the 9th Annual Blood Cover Art Contest. Vote now! Voting closes February 7, 2025 and the winner will be announced February 13, 2025. https://t.co/qbU9yiZEqk

[Dr Alan G Ramsay @RamsayLab]

🚨MRC-iCASE PhD studentship available🚨to join my lab at @KingsCollegeLon and study lymph node stroma-immune interactions in lung cancer to improve immunotherapy.
🗓️Closing date Tue 29 October 1PM
@KCL_MRCDTP #MRCDTP25 #PhDposition #London #AstraZeneca
https://t.co/0PhkhukBus

[Giulia De Rossi 🔬👀🤯 @GDR_tweets]

🚨New paper alert!🚨@LabWhiteford and I are excited to share our latest research published in @BrJPharmacol describing the development and pre-clinical testing 🧪of a novel peptide for neovascular (or wet) age-related macular degeneration (nvAMD).

(Quick 🧵below)

[Leandro Cerchietti @LCerchietti]

Our review article on the tumor microenvironment in B-cell lymphoma, part of a series collection, is available in Blood. Full access link
https://t.co/VL1T5Ok8Kk
@BloodJournal

[Ingo Ringshausen @i_ringshausen]

If you are keen to work as a POSTDOC with us in London on translational cancer research and tumour microenvironment signalling- please apply....5 days left!! https://t.co/WjRiU9FSsa

[Dr Alan G Ramsay @RamsayLab]

We are very grateful for a Fantastic editorial by Paul Moss! (2/2)
https://t.co/VJX8c2sopz

[Dr Alan G Ramsay @RamsayLab]

We are pleased to report our work revealing how ibrutinib enhances anti-cancer T cells, with cover image captured by Despoina! Thanks to group and all our amazing collaborators and funders. (1/2) #Immunotherapy #CLL #lymphoma @NIHFunding @BloodJournal

https://t.co/03QkfjlI3R

[Dr Alan G Ramsay @RamsayLab]

@i_ringshausen @CR_UK @SCICambridge @bloodcancer_uk Brilliant news Ingo!

[Dr Alan G Ramsay @RamsayLab]

Fantastic to read this spotlight commentary from the @theLundLab @cristaldi_vane

[Cancer Research @CR_AACR]

Online now:
Read the In The Spotlight Commentary— Structural vulnerabilities in DLBCL for enhanced treatment strategies, by @theLundLab discussing a recent @jclinicalinvest paper, from @RamsayLab.
https://t.co/3czdrPzNMo

[Journal of Clinical Investigation @jclinicalinvest]

Discovering the fibroblastic reticular cell in the immune tumor microenvironment in lymphoma: https://t.co/kGtOTMSuQT
Adam Yuh Lin & @ligordon highlight FRCs as a potential target to optimize immunotherapy for treatment of lymphoma; #Commentary
Related: https://t.co/OswZjHSfaj

[Dr Alan G Ramsay @RamsayLab]

@i_ringshausen Thanks Ingo! quite a puzzle!!

[Dr Alan G Ramsay @RamsayLab]

Very grateful to @ligordon and Adam Yuh Lin for their Commentary on our JCI article.
#Lymphoma #DLBCL #Immunotherapy
https://t.co/mBVxv5Z1V4

[Journal of Clinical Investigation @jclinicalinvest]

Fibroblasts suppress T cells in diffuse large B cell lymphoma: https://t.co/OswZjHSfaj
@RamsayLab @KingsCollegeLon
#Immunology #Oncology

[Dr Alan G Ramsay @RamsayLab]

@TSI_lab_LIH @BloodJournal @LIH_Luxembourg @Thomas_Helleday @pierreclose1 @JohannesMeiser @ArnBlomme Congratulations 👏🏻

[Dr Alan G Ramsay @RamsayLab]

Very grateful to @bloodcancer_uk for supporting this research

[Blood Cancer UK Research @BloodCancer_Res]

It's great to see our funding lead to an interesting #research output from the @RamsayLab. Hopefully future work will build on this to improve treatment options for an aggressive form of lymphoma 👨‍🔬🩸 @KingsCollegeLon
⬇️⬇️⬇️
https://t.co/JpD4BipKR1